Tilak Mandadi - Apr 1, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP, Chief Technology Officer
Signature
/s/ Tilak Mandadi
Stock symbol
CVS
Transactions as of
Apr 1, 2023
Transactions value $
$7,170,618
Form type
4
Date filed
4/4/2023, 04:34 PM
Previous filing
Sep 2, 2022
Next filing
Sep 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock (RSU) 99.8K Apr 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $7.17M +96.5K $74.31 96.5K Apr 1, 2023 Common Stock 96.5K $74.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023.
F2 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.